Search results for "chronic"

showing 10 items of 3309 documents

A Classification System for Decision-Making in the Management of Patients with Chronic Conditions

2021

Patients with chronic diseases are frequent users of healthcare services. The systematic use of stratification tools and predictive models for this group of patients can be useful for health professionals in decision-making processes. The aim of this study was to design two new classifier systems for detecting the risk of hospital admission for elderly patients with chronic conditions. In this retrospective cohort study, a set of variables related to hospital admission for patients with chronic conditions was obtained through focus groups, a health database analysis and statistical processing. To predict the probability of admission from the set of predictor variables, a logistic regression…

medicine.medical_specialtyGeography Planning and DevelopmentTJ807-830Sample (statistics)Management Monitoring Policy and LawLogistic regressionTD194-195Renewable energy sourcesolder peopleprimary careHealth caremedicineSampling (medicine)GE1-350Environmental effects of industries and plantsRenewable Energy Sustainability and the Environmentbusiness.industryrisk assessmentRetrospective cohort studydecision-makingFocus groupEnvironmental sciencesLong-term caremanagement of chronically ill patients; primary care; risk assessment; long-term care; decision-making; older people; screening; classification systemsEmergency medicinemanagement of chronically ill patientslong-term carebusinessRisk assessmentSustainability; Volume 13; Issue 23; Pages: 13176
researchProduct

Does chronic pain hinder physical activity among older adults with type 2 diabetes?

2021

Background: Physical activity (PA) is a key component in management of type 2 diabetes (T2D). Pain might be a barrier to PA especially among older adults with T2D, but surprisingly few studies have investigated the association between chronic pain and PA. Our aim was to evaluate the prevalence of chronic pain among older adults with T2D and to examine the association between chronic pain and PA while taking important life-contextual factors into account. Methods: Data of this register-based, cross-sectional study were collected in a survey among adults with T2D (n=2866). In the current study, only respondents aged 65–75 years were included (response rate 63%, n=1386). Data were analysed by …

medicine.medical_specialtyHealth (social science)media_common.quotation_subjectPhysical activityphysical activityType 2 diabetesNursingLogistic regressionPerceived health03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinemedicineSevere paint2dPsychologyT2D030212 general & internal medicineGeneral Psychologyolder adultsmedia_commonResponse rate (survey)030505 public healthdiabetesbusiness.industryOmvårdnadChronic painRPublic Health Global Health Social Medicine and EpidemiologyArticlesmedicine.diseaseBF1-990Folkhälsovetenskap global hälsa socialmedicin och epidemiologiFeelingPhysical therapykrooninen kipuMedicine0305 other medical sciencebusinesschronic painaikuistyypin diabetesfyysinen aktiivisuusikääntyneetResearch Article
researchProduct

Vaccination greatly reduces disease, disability, death and inequity worldwide

2007

In low-income countries, infectious diseases still account for a large proportion of deaths, highlighting health inequities largely caused by economic differences. Vaccination can cut health-care costs and reduce these inequities. Disease control, elimination or eradication can save billions of US dollars for communities and countries. Vaccines have lowered the incidence of hepatocellular carcinoma and will control cervical cancer. Travellers can be protected against "exotic" diseases by appropriate vaccination. Vaccines are considered indispensable against bioterrorism. They can combat resistance to antibiotics in some pathogens. Noncommunicable diseases, such as ischaemic heart disease, c…

medicine.medical_specialtyHealth PromotionDiseaseGlobal HealthHerd immunityEnvironmental healthPreventive Health ServicesGlobal healthmedicineHumansDisabled PersonsMortalityPovertyHealth policyPovertyImmunization Programsbusiness.industryHealth PolicyPublic healthfungiVaccinationPublic Health Environmental and Occupational Healthfood and beveragesHealth Status DisparitiesVaccinationSocioeconomic FactorsAcute DiseaseChronic DiseaseLife expectancyPublic HealthPolicy and PracticebusinessBulletin of the World Health Organization
researchProduct

Fibrosis markers and CRIM1 increase in chronic heart failure of increasing severity.

2014

AbstractBackground: Fibrosis suppressors/activators in chronic heart failure (CHF) is a topic of investigation.Aim: To quantify serum levels of fibrosis regulators in CHF.Methods: ELISA tests were used to quantify fibrosis regulators, procollagen type-(PIP)I, (PIP)III, collagen-I, III, BMP1,2,3,7, SDF1α, CXCR4, fibulin 1,2,3, BMPER, CRIM1 and BAMBI in 66 CHF (NYHA class I, n = 9; II, n = 34; III n = 23), and in 14 controls.Results: In CHF, TGFβR2, PIPIII, SDF1α and CRIM1 were increased. PIPIII correlated with CRIM1.Conclusions: The BMPs inhibitor CRIM1 is increased and correlates with higher levels of serum PIPIII showing an imbalance in favor of pro-fibrotic mechanisms in CHF.

medicine.medical_specialtyHealth Toxicology and MutagenesisClinical BiochemistryInflammationBiochemistryGastroenterologySeverity of Illness IndexBone morphogenetic protein 1ElectrocardiographyFibrosisInternal medicinemedicineEndothelial dysfunction heart fibrosis inflammationHumanscardiovascular diseasesEndothelial dysfunctionHeart Failurebusiness.industryMembrane ProteinsBone Morphogenetic Protein Receptorsmedicine.diseaseFibulinProcollagen peptidaseHeart failureImmunologyChronic Diseasecardiovascular systemBAMBImedicine.symptombusinesscirculatory and respiratory physiology
researchProduct

Disturbed Lipid Metabolism in Diabetic Patients with Manifest Coronary Artery Disease Is Associated with Enhanced Inflammation

2021

Background: Diabetic vasculopathy plays an important role in the pathophysiology of coronary artery disease (CAD) with oxidative stress as a strong mediator. This study aims to elucidate the underlying pathomechanisms of diabetic cardiac vasculopathy leading to coronary disease with an emphasis on the role of oxidative stress. Therefore, novel insights into antioxidant pathways might contribute to new strategies in the treatment and prevention of diabetic CAD. Methods: In 20 patients with insulin-dependent or non-insulin dependent diabetes mellitus (IDDM/NIDDM) and 39 non-diabetic (CTR) patients, myocardial markers of oxidative stress, vasoactive proteins, endothelial nitric oxide synthase …

medicine.medical_specialtyHealth Toxicology and MutagenesisInflammationmedicine.disease_causeArticleCoronary artery diseaseEnosDiabetes mellitusInternal medicinemedicineHumansoxidative stressbiologybusiness.industrydyslipidemiaPublic Health Environmental and Occupational HealthRLipid metabolismLipid Metabolismmedicine.diseasebiology.organism_classificationHeme oxygenaseEndocrinologynutritionDiabetes Mellitus Type 2inflammationdiabetes mellitusMedicinemedicine.symptombusinesschronic diseaseDiabetic AngiopathiesOxidative stressDyslipidemiacoronary artery diseaseInternational Journal of Environmental Research and Public Health
researchProduct

Telemonitoring in chronic pain management using smartphone apps: a randomized controlled trial comparing usual assessment against app-based monitorin…

2020

Background. The usefulness of mHealth in helping to target face-to-face interventions for chronic pain more effectively remains unclear. In the present study, we aim to test whether the Pain Monitor mobile phone application (app) is well accepted by clinicians, and can help improve existent medical treatments for patients with chronic musculoskeletal pain. Regarding this last goal, we compared three treatment conditions, namely usual treatment, usual treatment with an app without alarms and usual treatment with an app with alarms. All treatments lasted one month. The three treatments were compared for all outcomes, i.e., pain severity and interference, fatigue, depressed mood, anxiety and a…

medicine.medical_specialtyHealth Toxicology and Mutagenesismedia_common.quotation_subjectPsychological interventionlcsh:MedicineAngerArticlelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmental disordersmedicineHumansPain Management030212 general & internal medicinemHealthSalut mentalmedia_commonClinical eventsbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthChronic painecological momentary assessmenttelemonitoringmedicine.diseaseMobile Applicationssmartphone appClinical AlarmsSmartphone apprandomized controlled trialPhysical therapyAnxietySmartphonemedicine.symptomChronic Painbusinesschronic pain030217 neurology & neurosurgery
researchProduct

Stress, anxiety and depression in heart disease patients: A major challenge for cardiac rehabilitation

2016

International audience; Cardiovascular events and emotional disorders share a common epidemiology, thus suggesting fundamental pathways linking these different diseases. Growing evidence in the literature highlights the influence of psychological determinants in somatic diseases. A patient's socio-economic aspects, personality traits, health behavior and even biological pathways may contribute to the course of cardiovascular disease. Cardiac events often occur suddenly and the episode can be traumatic for people not prepared for such an event. In this review of the literature, the authors tackle the question of psychobiological mechanisms of stress, in a pathophysiological approach to funda…

medicine.medical_specialtyHeart DiseasesHeart diseasemedicine.medical_treatment[ SDV.MHEP.PSM ] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthCardiac rehabilitationContext (language use)[ SCCO.PSYC ] Cognitive science/PsychologyDiseaseAnxiety030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsAdaptation PsychologicalmedicineHumansOrthopedics and Sports MedicineBig Five personality traitsPsychiatryDepression (differential diagnoses)RehabilitationDepressionRehabilitationBrainHeartmedicine.diseaseAnxiety disorderAnxietyChronic stressmedicine.symptomPsychologyStress Psychological030217 neurology & neurosurgeryAnxiety disorderClinical psychology
researchProduct

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

2008

Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontains surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, …

medicine.medical_specialtyHeart diseasemedicine.medical_treatmentAdrenergic beta-AntagonistsElectric CountershockPHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.Catheter ablationElectrocardiographyPharmacotherapyInternal medicineAtrial FibrillationDrug DiscoverymedicineHumanscardiovascular diseasesChildUltrasonographyPharmacologyFibrillationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Cardiac Pacing ArtificialAtrial fibrillationCalcium Channel Blockersmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareAtrial fibrillation atrial flutter pharmacological therapy childrenAtrial FlutterChronic DiseaseCatheter Ablationcardiovascular systemCardiologymedicine.symptombusinessAnti-Arrhythmia AgentsElectrocardiographyAtrial flutterCurrent Pharmaceutical Design
researchProduct

Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched

2021

Since molecules with direct-acting antiviral (DAA) became available, the landscape of the treatment of hepatitis C virus (HCV) infection has completely changed. The new drugs are extremely effective in eradicating infection, and treatment is very well tolerated with a duration of 8-12 wk. This review aims to report the outstanding clinical benefits of DAA and to highlight their critical disadvantages, identifying some clinically relevant hot topics. First, do the rates of virological response remain as high when patients with more advanced cirrhosis are considered? Large studies have shown slightly lower but still satisfactory rates of response in these patients. Nevertheless, modified sche…

medicine.medical_specialtyHepatitis B virusHepatitis C virusHepatitis C virus/hepatitis B virus coinfection.HepacivirusHypoglycemiamedicine.disease_causeGastroenterologyAntiviral Agents03 medical and health sciencesLiver diseasechemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicinemedicineAnimalsHumansAdvanced cirrhosisDirect antiviral activityHepatitis B virusbusiness.industryHepatitis C virusCoinfectionIncidence (epidemiology)RibavirinGastroenterologyvirus diseasesMinireviewsGeneral MedicineHepatitis C Chronicmedicine.diseaseHepatitis BHepatitis Cdigestive system diseaseschemistry030220 oncology & carcinogenesisCoinfection030211 gastroenterology & hepatologyNeoplasm Recurrence LocalLiver cancerbusinessLiver cancerChickensWorld Journal of Gastroenterology
researchProduct

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

2005

Background/Aims: Prediction of sustained virological response (SVR) during treatment would allow clinicians to identify patients most likely to benefit from therapy. Methods: Retrospective analysis of data from 1121 adults with chronic hepatitis C treated for 48 weeks with peginterferon alfa-2a (40 KD) 180 mu g/week plus placebo or ribavirin (1000/1200 mg/day), or interferon alfa-2b 3 MIU three times/week plus ribavirin in a randomized, multinational, study. Results: 67% of patients treated with peginterferon alfa-2a (40 KD)/ribavirin with early virological responses (HCV RNA negative or >= 2 log(10) decrease) at week 12 had SVRs at week 72 (HCV RNA 80 % of the planned ribavirin dose. Concl…

medicine.medical_specialtyHepatitis B virusviral hepatitisAlpha interferonPeginterferon-alfaInterferon alpha-2medicine.disease_causeGastroenterologyAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundpredictabilityInternal medicineRibavirinmedicinechronic hepatitis CHumansProbabilityRetrospective StudiesHepatitis B viruspeginterferon alfa-2a (40 KD)treatmentHepatologyDose-Response Relationship Drugbusiness.industryRibavirinvirus diseasesInterferon-alphaHepatitis CHepatitis C ChronicViral Loadmedicine.diseasedigestive system diseasesRecombinant ProteinsTreatment OutcomechemistryImmunologyRNA ViralDrug Therapy Combinationsustained virological responseViral hepatitisbusinessViral loadPeginterferon alfa-2amedicine.drugJournal of hepatology
researchProduct